Literature DB >> 8899308

Induction of bimodal programmed cell death in malignant cells by the derivative Ukrain (NSC-631570).

A Liepins1, J W Nowicky, J O Bustamante, E Lam.   

Abstract

Selective induction of malignant cell death is one of the major goals of effective and safe chemotherapy. Recent developments in the understanding of programmed cell death (PCD) or apoptosis are expected to provide new leads for a safer chemotherapy. The authors investigated whether the semisynthetic alkaloid thiophosphoric acid derivative Ukrain (NSC-631570) could induce PCD or apoptosis in human K562 leukaemia cells. Results showed that Ukrain induced two distinct modalities of cell death programmes. One modality corresponded morphologically to classical apoptosis or PCD characterized by blebbing and shedding of membrane vesicles with concomitant 51Cr release; however, the Ukrain-induced apoptosis was not associated with the characteristic nuclear DNA fragmentation. Higher concentrations of Ukrain induced a second cell death programme characterized by cell surface blister formation, high specific 51Cr release and extensive DNA polyploidy. These two cell death programmes are distinct from each other in that they are interphased by a silent period characterized by normal cell morphology and reduced specific 51Cr release.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8899308

Source DB:  PubMed          Journal:  Drugs Exp Clin Res        ISSN: 0378-6501


  4 in total

1.  Transcriptional down regulation of hTERT and senescence induction in HepG2 cells by chelidonine.

Authors:  Sakineh Kazemi Noureini; Michael Wink
Journal:  World J Gastroenterol       Date:  2009-08-07       Impact factor: 5.742

2.  Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway.

Authors:  Daniel Habermehl; Bernd Kammerer; René Handrick; Therese Eldh; Charlotte Gruber; Nils Cordes; Peter T Daniel; Ludwig Plasswilm; Michael Bamberg; Claus Belka; Verena Jendrossek
Journal:  BMC Cancer       Date:  2006-01-17       Impact factor: 4.430

Review 3.  Ukrain - a new cancer cure? A systematic review of randomised clinical trials.

Authors:  E Ernst; K Schmidt
Journal:  BMC Cancer       Date:  2005-07-01       Impact factor: 4.430

4.  Textural, Structural and Biological Evaluation of Hydroxyapatite Doped with Zinc at Low Concentrations.

Authors:  Daniela Predoi; Simona Liliana Iconaru; Aurélien Deniaud; Mireille Chevallet; Isabelle Michaud-Soret; Nicolas Buton; Alina Mihaela Prodan
Journal:  Materials (Basel)       Date:  2017-02-25       Impact factor: 3.623

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.